11:13 AM EDT, 08/19/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts kicked off the week on a positive note late Monday morning, rising 0.88% to 1,457.38 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firms Evaxion Biotech ( EVAX ) and BioNTech (BNTX), which rose 6.3% and 4.2%, respectively. They were followed by petroleum refiner Equinor ( EQNR ) and financial services company Banco Bilbao Vizcaya Argentaria ( BBVA ) , which were up 2.9% and 2.4%, respectively.

The decliners from continental Europe were led by furniture maker Natuzzi (NTZ), which fell 3.3%, and medical device maker EDAP TMS ( EDAP ) , which lost 1.7%. They were followed by biopharmaceutical company Genfit ( GNFT ) and accommodation booking company trivago (TRVG), which were down 1.6% and 0.5%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics ( AKTX ) and Amarin ( AMRN ) , which advanced 12% and 5.5%, respectively. They were followed by biopharmaceutical companies Bicycle Therapeutics ( BCYC ) and Biodexa Pharmaceuticals ( BDRX ) , which increased 4.3% and 2.4%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies TC Biopharm ( TCBP ) and NuCana ( NCNA ) , which lost 4.9% and 1.4%, respectively. They were followed by biopharmaceutical companies Adaptimmune Therapeutics ( ADAP ) and Verona Pharma ( VRNA ) , which were off 0.5% each.